Claimed he owned 200K shares between the share price of .42 and .47. If I am incorrect he can easily show us the trades. Like his actual bill for a fake trip to Tahiti. Now what is arlo valuation after not listening to my advice.....200K /40= 5K shares x 3.72= $18,600 = the 100K shares of mining he claimed he sold at .10 and his value is $28,600. Now what did he begin with 200K x .42 average= $84K. So by him not cleaning out his ears and instead using the k9uwa id, this cost him $55,400.
The 515M shares I warned about cost him large. The biotech clowns lack the attention to details. Today arlo needs $11 move to breakeven. Pretty difficult to get that kind of move with a biotech without revenues. Frost saw the $20M low hanging fruit and sold his followers out. The insiders of Scavf received 515M shares, today still valued at $48M, the biotech clowns who paid double for their shares, now see a company go from $112M on paper to now $22M.
Maybe arlo was too busy inventing new id's to understand that adding 515M shares wasn't going to immediate value this company at $355M. The value he needed to support his buys in the $18's. Today arlo has to invent imaginary flight connections, failing to include the airport code. I sometimes forget that arlo is 70 years old, with the intellect of a 8 year.
3.16M deferred revenues
Svac had $10M cash at the end of the 1Q. They also have on the books deferred revenues of 3.16M, with 1.57M listed as short term and 1.63M listed as long term. They believe that the $10M in cash will last them 12 months?????
I think hidden in these reports is that they have a strong contract to manufacture compounds for 10 different ph1 trials by other companies. They also have a deal with OPK to manufacture something on a billing basis. They do not mention the Dnase enzymes stuff at all.
As investors we have to understand where the funding will come from. Can LVP get legs, can they manufacture drugs on scale and profit from it. What exact did Frost see here? Missing from the Web page now is anything about Svac second drug. The GVHD? Curious minds want to know where did that go off too?
They also put out a SEC filing that they will use their web page instead of PR's to announce things. They suggest you get the VBIV alerts, so you are updated as fast as possible. Is this a cost saving move?
With a stock that is already down 75% from the highs, I think we as investors need a little bone thrown our way. The insiders handed themselves 515M shares and 650M divided by 40.
I don't expect an intelligent discussion, since most of the biotech investors here, can't tie their own shoes. We found that out at $18.80 when they just had blinders on. What could have been a very intelligent discussion, turned into a cluster F, with K(UWA and arlo, cdavis, Dk1949. Shame these clowns were this stupid. But then again they just like to sniff the hinney of Frost, with no brains to back their heads out of the crack.
I sense a surprise is coming. Things always take more time then we wish with a biotech. The unsophisticated think just the opposite. Well let's let arlo place his thumbs. I don't mind reproducing this 20 times. It's not like we will get anything intelligent from that side anyways.
Chase another wind mill arlo.
Arlo let's see 10 thumbs down here also. Maybe you can get federal aid being this dumb.
Looks like I don't need a new game, you seem to rile old arlo, better then I can. 10 thumbs because you showed up. Please chime in more, getting arlo to change his id that many times......PRICELESS.
svacfakeid39s57 • 38 minutes ago
users liked this posts
users disliked this posts
They are suppose to have the CMV trial started in the next 6 weeks. Still nothing up on the Clinical trial site. The $25M they needed to raise was canceled, so I expect some news on funding. Could they just license the vac-b to GSK for a nice large check?
There is a new update presentation on VBI site. It includes both companies and their outline going forward. I figure they need about $100M to advance the CMV, GBM, Vac-b, RSV and maybe a year away from seeing the cold storage benefits. They also state they are close to a third collaboration on the thermo stability.
Can he remember which id posted where? The counts are not even arlo and this is not fun unless you even this out and change those id's. You can be the poster child for stupid.
Arlo try this one also. You can place thumbs all over the place. You are just a clown that over paid by a factor of 4 for svacf shares. Even though I tried to talk you off the ledge.
Deb here is a link to why the CT was granted to July 25, 2018.
The trial for PVSRIPO data:
Estimated Enrollment: 65
Study Start Date: January 2012
Estimated Study Completion Date: January 2018
So there could be why we got CT treatment on a license deal. Of course this is speculation, but since both Duke and VBIV are involved with a investigating our GBM, there could be something there. Frost once called this merger a game changer.
Hope we don't have to wait till 2018 for some news. The move today, maybe be some news on the way. Joint partnership and some cash would be very welcome right now. If the biotech clowns can get back to even, I will be up $100K.
Then immediate a company with a drug VAL-083 jumps on the band wagon. I figure they want to catch a piece of the hype. You have to read everything you can find and I want arlo to satisfy his stupidity by place thumbs everywhere. As some of you are now getting. He is a perpetual loser every board he goes on. As rory, as edbi, as spanspur. The same thing always comes with it. He tries so hard and he always looks like a idiot.
I can do this all day and if he's dumb enough to work this hard, I egg him on.
They think 60 minutes may have advanced something before it really is proven. Here is the article:
A glioblastoma therapy touted in a "60 Minutes" report that aired Sunday evening, focusing on the use of the polio virus to treat glioblastoma, isn’t a particularly new idea and results are still unpublished -- but some oncologists are worried that patients might not have gotten that message from the program.
The segment highlighted an approach being tested by researchers at Duke University involving an engineered poliovirus that is aimed at inducing an immune attack on glioblastoma tumor cells.
Neuro-oncologist and team member Henry Friedman, MD, reported an increase in median survival of over 6 months. "So we've got patients that are out as far as 33, 34 months," he told 60 Minutes. "That is just unheard of in this disease."
Study leader and director of Preston Robert Tisch Brain Tumor Center Darell Bigner, MD, PhD, did not call the patients "cured." But he reported that four patients are "in remission" (defined as living longer than 6 months).
On the other hand, half of the 22 patients in the Duke trial have died.
Since the story aired, patients have been calling Duke from all over the country, officials at Duke told MedPage Today. The Brain Tumor Center has received hundreds of calls and more than 200 online inquiries.
In 35 minutes arlo changed his id 6 times. He is such a loser. He got busted on svacf board, actually replying to himself. Thanks for the compliment. I just watch the video by 60 minutes. I agree long shot that vbiv is the company they licensed it with. However, their are two CT filings that allow the company to keep certain news confidential.
This may fall under that treatment, because with the results that Duke is having, if leaked could steal the value they expect down the road, by being bought out. For some reason we have stirred up arlo's immaturity of using his thumbs and he's like a mad dog right now. He wants so badly to have a voice in here and he knows that he offers nothing.
Paying $18.80 a share when you were warned, is eating at him. He should actually be happy that there's a glimmer of hope for his bad investing. Look at the two CT filing on VBIV and see what you think.
I'm sure they saw your photo of the sex change and they are thumbing downing how you look as a women. Don't be such a drama queen. BTW watch the IQD, it may change your tune here. Now shave your legs and act like a lady.
Knowing you need $153 a share on VAPR to breakeven, you should worry about yourself.
I'm not talking about PVCT and Pv-10. So you do not have to persuade me. I'm more interested in what VBIV will do with their vaccine + check point inhibitors. I think most have given up on PVCT ever delivery on anything. First the CEo would not steal if they were close to something.
The longs here are getting a good lesson in what to watch out for.
Good point, but would you want the side effects of chemo or a check point inhibitor? Here is a recent article about what you are referencing.
Checkpoint inhibitors can produce immune-related side effects in any organ or system of the body: the skin, gastrointestinal tract, endocrine glands, liver, nervous system, and pulmonary system. They can cause inflammatory conditions such as colitis, hypophysitis, nephritis, and uveitis—anything that ends in -itis. The most common side effects, however, are fatigue, rash, mild nausea, and decreased appetite, all of which are relatively easy for the patient to tolerate and the physician to treat. We also commonly see elevated or decreased thyroid hormone levels, which we are able to treat.
Approximately 70% of patients receiving a checkpoint inhibitor experience some type of side effect. Only 10% of patients experience a grade 3 or 4 side effect, however. Those percentages are pretty consistent across all of the checkpoint inhibitors. It is important to remember that clinical trials have shown that checkpoint inhibitors produce less toxicity than does single-agent chemotherapy. Side effects that cause death or require discontinuation of the checkpoint inhibitor are rare.